Evidence for feasibility of fetal trophoblastic cell based noninvasive prenatal testing+
The goal was to develop methods for detection of chromosomal and subchromosomal abnormalities in fetal cells in the mother's circulation at 10 16 weeks' gestation using analysis by array comparative genomic hybridization (CGH) and/or next generation sequencing (NGS)
Prenatal diagnosis